Intra-Cellular Therapies

Home » Intra-Cellular Therapies

Secondary

Intra-Cellular Therapies

J. P. Morgan Securities, Leerink Partners Description:  Intra-Cellular Therapies is developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases and diseases of the elderly, including Parkinson’s and Alzheimer’s disease.

Symbol

ITCI (trades on OTC)

Last Closing Price
$19.23

Shares
7,000,000

Anticipated Date
TBD

Underwriters
J.P. Morgan, Leerink Partners

To view the prospectus for Intra-Cellular Therapies, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253